NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia 2017 Jul;31(7):1648-1650
Date
04/13/2017Pubmed ID
28400617Pubmed Central ID
PMC5508075DOI
10.1038/leu.2017.115Scopus ID
2-s2.0-85021748993 (requires institutional sign-in at Scopus site) 27 CitationsAuthor List
Hao M, Franqui-Machin R, Xu H, Shaughnessy J Jr, Barlogie B, Roodman D, Quelle DE, Janz S, Tomasson MH, Sanderson RD, Qiu L, Frech I, Tricot G, Zhan FAuthor
Siegfried Janz MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Bone and BonesCell Differentiation
Glucuronidase
Humans
Multiple Myeloma
NIMA-Related Kinases
Osteoclasts
